Search

Longitudinal Efficacy and Safety Modeling and Simulation Framework to Aid Dose Selection of Belantamab Mafodotin for Patients with Multiple Myelo.

Therapeutic area :

Collins J., Noort van M., Rathi C., Post T.M., Struemper H., Jewell  R.C., FerronBrady G. Longitudinal Efficacy and Safety Modeling and Simulation

Framework to Aid Dose Selection of Belantamab Mafodotin for Patients with Multiple Myelo. CPT Pharmacometrics Syst. Pharmacol. 2023 [Link to publication].

Our expertise

Peripheral Nervous System Pain Anesthesiology Blood disorders Paediatrics Oncology Lung Diseases Biologicals Diabetes Cardiovascular Endocrinology/Sexual health Methods Anti-infectives and immunology Safety pharmacology Gastrointestinal Diseases General modelling CNS